LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Age-Related Lack of Attachment Proteins Diminishes Regenerative Ability of Muscle Tissue

By LabMedica International staff writers
Posted on 20 Jul 2016
Image: A normal muscle (left) is compared to a muscle lacking beta1-integrin (right) (Photo courtesy of Chen-Ming Fan, Michelle Rozo / Carnegie Institution for Science).
Image: A normal muscle (left) is compared to a muscle lacking beta1-integrin (right) (Photo courtesy of Chen-Ming Fan, Michelle Rozo / Carnegie Institution for Science).
The cellular attachment proteins fibronectin and beta1-integrin have been linked to age-related changes that limit the ability of muscle tissue to regenerate and in the reduced maintenance of muscle stem cells.

Integrins are transmembrane receptors that mediate the attachment between a cell and the tissues that surround it, such as other cells or the extracellular matrix (ECM). Fibronectin is a high-molecular weight ECM glycoprotein that binds to attachment proteins such as integrins. Similar to integrins, fibronectin binds extracellular matrix components such as collagen, fibrin, and heparin sulfate proteoglycans.

Investigators at the Carnegie Institution for Science (Baltimore, MD, USA) and colleagues at the École Polytechnique Fédérale de Lausanne (Switzerland) combined efforts to study the molecular basis for the detrimental effects of aging on muscle tissue.

They reported in two papers published in the July 4, 2016, online edition of the journal Nature Medicine that there was a strong link between the action of beta1-integrin and fibronectin in the deterioration of muscle during aging. Beta1-integrin was found to be diminished in aged muscle stem cells (MuSCs). Artificial removal of beta1-integrin from youthful muscles caused them to behave as if they were old, while activation of beta1-integrin in mice with aged muscles restored their regenerative abilities to youthful levels.

Similarly, the aged stem cell niche in skeletal muscle contained substantially reduced levels of fibronectin (FN), leading to detrimental consequences for the function and maintenance of MuSCs. Deletion of the gene encoding FN from young regenerating muscles replicated the aging phenotype and led to a loss of MuSC numbers. Reconstitution of FN levels in the aged niche remobilized stem cells and restored youth-like muscle regeneration. Improvement in regeneration, strength, and function were also seen when this treatment was applied to animals with muscular dystrophy.

"Inefficient muscular healing in the elderly is a significant clinical problem and therapeutic approaches are much needed, especially given the aging population-and, I am including myself in this population," said senior author Dr. Chen-Ming Fan, researcher in the department of embryology at the Carnegie Institution for Science. "Finding a way to target muscle stem cells could greatly improve muscle renewal in older individuals. Taken together, our results show that aged muscle stem cells with compromised beta1-integrin activity and aged muscles with insufficient amount of fibronectin are both root causes of muscle aging. This makes beta1-integrin and fibronectin very promising therapeutic targets."

Related Links:
Carnegie Institution for Science
École Polytechnique Fédérale de Lausanne
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Sample Transportation System
Tempus1800 Necto

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more